Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Zymo Research consigue el marcado CE IVD para sus dispositivos de recolección de muestras
  • India - English
  • Brazil - Português
  • Latin America - español
  • USA - Deutsch
  • USA - Français

Zymo Research Corp. Logo

News provided by

Zymo Research Corp.

Sep 28, 2020, 12:35 ET

Share this article

Share toX

Share this article

Share toX

Las muestras seguras y fiables se preservan a temperatura ambiente para aplicaciones IVD

IRVINE, California, 28 de septiembre de 2020 /PRNewswire/ -- Zymo Research anunció que tres de sus dispositivos de recolección DNA/RNA Shield™ 1) DNA/RNA Shield™ collection tube w/ swab, 2) DNA/RNA Shield™ Saliva/Sputum Collection Kit, y 3) DNA/RNA Shield™ Fecal Collection Tube ya cuentan con el certificado de marcado CE IVD para aplicaciones de diagnosis in vitro (IVD).

Continue Reading
Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices.
Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices.

La gama de productos DNA/RNA Shield™ incluye la recolección de muestras, preservación y dispositivos de transporte para especímenes médicos utilizados en la investigación, estando ya disponibles para su diagnosis in vitro (por ejemplo, test de la COVID-19). Con el fin de recibir el marcado CE IVD, los científicos de Zymo Research han recolectado datos de rendimiento amplios sobre las muestras (patógenos) de inactivación y preservación del ácido nucleico. Los resultados han confirmado una estabilización sin precedentes de las muestras (semanas/meses) y del ADN (muchos años) cuando se han almacenado las muestras a temperatura ambiente. Como DNA/RNA Shield™ inactiva de forma inmediata los patógenos, incluyendo SARS-CoV-2, el virus que causa la COVID-19, el transporte de muestras es mucho más seguro para los profesionales de laboratorio y trabajadores de primera línea.

"Estamos estandarizando la colección de muestras en los casos clínicos y de investigación", explicó el doctor Stanislav Forman, de Zymo Research Corp. "Esta tecnología proporciona un nivel de satisfacción para los primeros encuestados y proveedores de servicio; al tiempo que se inactivan los patógenos, y se mantiene el ácido nucleico característico. El marcado CE IVD nos permite apoyar a muchos más laboratorios clínicos y organizaciones de todo el mundo, incluyendo los que realizan pruebas de la COVID-19 durante la actual pandemia".

El marcado CE IVD llega en un momento vital, al tiempo que con muchos los laboratorios y las organizaciones que necesitan dispositivos de recolección de muestras para apoyar los esfuerzos de pruebas mundiales de la COVID-19 con su producto DNA/RNA Shield™, incluyendo el Corona Testing Centre del Aeropuerto de Stuttgart. El centro de pruebas está operado por medio de CeGaT GmbH, proveedor de diagnosis genética y de servicios NGS, con sede en Tübingen, Alemania. Para las pruebas, la colección del tubo con hisopo DNA/RNA Shield™ se ha utilizado para recolectar muestras nasofaríngeas de los pasajeros de los aeropuertos, que se han sometido a control para el ARN viral SARS-CoV-2 utilizando el test de la reacción en cadena de la polimerasa en tiempo real (RT-PCR). Los resultados del test están disponibles al día siguiente como parte de los esfuerzos destacados para contener la propagación de la COVID-19.

"Nos basamos en los tubos de recolección de muestras de Zymo Research para la diagnosis aguda del SARS-CoV-2", indicó el doctor med. Dr. rer. nat. Saskia Biskup, consejero delegado de Praxis para Humangenetik Tübingen y CeGaT GmbH. "Valoramos las capacidades de inactivación de la solución CE IVD con certificado DNA/RNA Shield™, lo que nos permite conseguir una gestión de muestras más segura y conseguir un rendimiento superior en el laboratorio".

Si desea más información acerca de DNA/RNA Shield™ y los dispositivos de la colección, visite la página web de Zymo Research o contacte con ellos por medio del e-mail a través de [email protected].

Acerca de Zymo Research Corp.
Zymo Research es una compañía privada que presta servicio a la comunidad científica y de diagnóstico con herramientas de biología molecular de vanguardia desde 1994. "La belleza de la ciencia es hacer simples las cosas" es su lema, y se refleja en todos sus productos, desde sus tecnologías de epigenética hasta las de purificación de ADN/ARN. Históricamente reconocida como líder en epigenética, Zymo Research está derribando fronteras con soluciones novedosas para la obtención de muestras, mediciones microbiomicas, dispositivos de diagnóstico y tecnologías de secuenciación de última generación de alta calidad y fáciles de usar. Siga a Zymo Research en Facebook, LinkedIn, Twitter e Instagram.

Foto - https://mma.prnewswire.com/media/1281947/DNA_RNA_Shield_Collection_Devices.jpg

Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg

Related Links

http://www.zymoresearch.com

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Zymo Research Advances Wastewater Surveillance as Sponsor of the Microbes in Wastewater Symposium 2026

Zymo Research Advances Wastewater Surveillance as Sponsor of the Microbes in Wastewater Symposium 2026

Zymo Research Corporation, a global leader in molecular biology and pathogen detection, is proud to sponsor the Microbes in Wastewater Symposium...

Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights

Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights

Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.